Rafik Fellague-Chebra

• Exploring the Microbiome & Colorectal Cancer: How gut microbiota modulate colorectal cancer risk and progression, evaluating the influence of microbial metabolites (e.g., butyrate) on tumor microenvironment and elucidating microbiome interactions with immunotherapy and chemotherapy response
• Other GI Cancers (Pancreatic, Gastric & Esophageal): exploring key microbiome-driven mechanisms in upper GI cancers, the role of bacterial dysbiosis in inflammation and tumorigenesis, and exploring current and emerging microbiome-targeted therapeutic strategies 
• Translating Microbiome Research into Oncology Practice: including strategies for microbiome modulation, the potential for microbiome-based biomarkers in GI cancer detection and challenges and future directions in integrating microbiome science into cancer care 

Start-Up Showcase Immerse yourself in a showcase of cutting-edge research and technologies as short-listed microbiome start-ups unveil their unique approaches to drug development.

You, and a judging panel of experts, will meet the brilliant minds behind microbiome start-ups, understanding their expertise, commercial strategies for success and passion that drives their mission to revolutionize today’s drug development landscape.

With prizes at stake, join us for a dynamic session where microbiome start-ups take center stage and a panel of VC’s and investors decide who to award as the winner of the Microbiome Movement Start-Up Showcase 2025!

Start-up Showcase Finalists Announced!

• Kevin Horgan, Head of Research & Development, Melius MicroBiomics
• Zoe Watson, Co-Founder & Chief Executive Officer, Microvitality

The 2025 Winner Receives A Free Pass to Attend Next Years’ Summit & a Speaking Position!